Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-01

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Visual Function After Bilateral Implantation of AcrySof® Toric

NCT00758550

Visual Function

COMPLETED PHASE4

Visual Function After Implantation of AcrySof® Toric Lens

NCT01074606

Cataract

TERMINATED PHASE4

Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens

NCT04652037

Cataract Presbyopia Corneal Astigmatism

COMPLETED NA

Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL)

NCT04098367

Aphakia

COMPLETED NA

Reading Performance in Patients With Acrysof IQ Vivity Versus Acrysof IQ

NCT05194657

Cataract

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective interventional case series of 30 patients who underwent cataract surgery and bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens. This study is represented by an Asian cohort of patients and the study evaluations were focused not only on clinical visual outcomes but also on "real-life" patient reported outcomes such as dysphotopsias, spectacle independence and daily visual tasks all of which were measured at 1 month and up to 3 months postoperatively. The objective would be to provide insight into the performance of this intraocular lens in Asian patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Senile Intraocular Lens Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All eyes

All eyes implanted with AcrySof™ IQ Vivity™ Toric intraocular lens

Group Type EXPERIMENTAL

AcrySof™ IQ Vivity™ Toric intraocular lens

Intervention Type DEVICE

Uneventful phacoemulsification and implantation of IOL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AcrySof™ IQ Vivity™ Toric intraocular lens

Uneventful phacoemulsification and implantation of IOL

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged 18 years or older
* bilateral significant cataracts
* bilateral significant corneal astigmatism

Exclusion Criteria

* previous refractive surgery
* amblyopia
* strabismus
* any ocular co-morbidity which could impact on final visual acuity
* pre-existing zonular weakness
* capsular instability or compromise

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No